Overview

• The U.S. government has enacted a 57% reduction in funding for the Congressionally Directed Medical Research Program, cutting $185 million from cancer research programs.
• Glioblastoma, kidney, lung, and pancreatic cancers have lost all federal research funding under the new spending bill.
• Over 10,000 jobs have been cut at the National Institutes of Health and other health agencies, raising concerns about delays in cancer research and treatment advancements.
• Meghan McCain has publicly criticized the cuts, highlighting their impact on glioblastoma research and urging Congress to restore funding.
• Advocacy groups like ACSCAN are mobilizing petitions to pressure lawmakers to reverse the funding cuts, emphasizing the critical need for continued cancer research.